SEC Filing Summary for BioNTech SE

This filing details stock transactions made by Sahin Ugur, the Chief Executive Officer and 10% owner of BioNTech SE. On September 3, 2026, Ugur sold 45,000 ordinary shares at a price of $102.85 per share, leaving 813,209 shares. On September 4, 2026, an additional 31,500 shares were sold at $103.52 per share, resulting in 781,709 shares remaining. These transactions were executed under a Rule 10b5-1 trading plan established on June 3, 2026. The filing is a Form 4, indicating a change in beneficial ownership.